Cancer Immunology, Immunotherapy Issues Research Articles in November 2022 Edition
September 29, 2022
September 29, 2022
BASEL, Switzerland, Sept. 29 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles on the following topics in its November 2022 edition:
Original Articles:
* Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors
* Camrelizumab combined with apatinib and S-1 . . .
Original Articles:
* Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors
* Camrelizumab combined with apatinib and S-1 . . .